SPDE Speedus Corp (CE)

Zargis CTO to Speak at Medical Devices Conference PRINCETON, N.J., March 15 /PRNewswire/ -- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (NASDAQ:SPDE) announced today that its founder and chief technology officer, Dr. Raymond Watrous, has been invited to speak on the topic of auscultation at the April 13-14 Design of Medical Devices Conference in Minneapolis, MN. Dr. Watrous' talk will focus on the history, science and clinical benefits of computer-aided auscultation of the heart. The Design of Medical Devices Conference is sponsored by the University of Minnesota's Department of Mechanical Engineering along with an assortment of the world's leading medical device manufacturers -- including Medtronic, St. Jude Medical Center, Guidant, Boston Scientific and 3M. The conference's primary objective is to bring together medical device designers, manufacturers, researchers and public sector representatives to discuss technologies and share perspectives on issues related to current and future medical device design. Dr. Watrous is a leading authority on the analysis, interpretation and monitoring of biomedical signals. Prior to founding Zargis Medical, Dr. Watrous spent 17 years with Siemens Corporate Research, where he was engaged in speech recognition and biomedical signal processing research and led the development of the technology underlying Zargis' core Cardioscan(TM) product. Cardioscan is the first and only FDA cleared computer-assisted medical device designed to aid physicians in analyzing heart sounds for the identification of suspected murmurs, a potential sign of heart disease. Dr. Watrous has also published numerous technical articles and is the lead inventor for nine core Zargis patent applications in the field of computer-aided diagnostics. For information on the Design of Medical Devices Conference, which will be held at the Radisson Hotel Metrodome in Minneapolis, visit the conference Web page at http://www.me.umn.edu/dmd/. About Zargis Medical Corp. Zargis Medical Corp. develops advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG (NYSE:SI), and Speedus Corp. co-invested to develop and market an advanced acoustic technology designed to detect heart abnormalities identified through analysis of heart sounds. About Speedus Corp. Speedus Corp. is a holding company with controlling interests in Zargis Medical Corp. and F&B Gudtfood Holdings, Inc. Speedus Corp. also owns broadband intellectual property and controls licensed wireless frequencies. For additional information about Zargis Medical, Speedus Corp. or the Cardioscan product, contact Peter Hodge at 888.773.3669 (ext. 23) or , or visit the following Web sites: http://www.zargis.com/ and http://www.speedus.com/ Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts. DATASOURCE: Zargis Medical Corp. CONTACT: Peter Hodge of Zargis Medical Corp., 1-888-773-3669, ext. 23, or Web site: http://www.zargis.com/ http://www.speedus.com/ http://www.me.umn.edu/dmd

Copyright